skip over navigation

A Safety, Efficacy, Randomized, Double Blind, Placebo Controlled, Crossover Trial of Lamictal in the Treatment of Post-Herpetic Neuralgia

Brief Project Description

Sponsor: GlaxoSmithKline
Statistician: Heather A. Young, PhD, MPH
The major goals of this trial are to determine the clinical effectiveness of Lamictal in the treatment of post-herpetic neuralgia and to evaluate the safety of the drug for this use.

Faculty

Department

site maintained by MCCM | last updated 09 February 2012 | Site Map